nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP2C19—Ifosfamide—testicular cancer	0.175	0.301	CbGbCtD
Moclobemide—CYP2C9—Ifosfamide—testicular cancer	0.145	0.25	CbGbCtD
Moclobemide—CYP1A2—Etoposide—testicular cancer	0.077	0.133	CbGbCtD
Moclobemide—CYP2C9—Cisplatin—testicular cancer	0.0707	0.122	CbGbCtD
Moclobemide—CYP2D6—Vinblastine—testicular cancer	0.0705	0.121	CbGbCtD
Moclobemide—CYP2D6—Doxorubicin—testicular cancer	0.0433	0.0745	CbGbCtD
Moclobemide—Malaise—Cisplatin—testicular cancer	0.00123	0.00294	CcSEcCtD
Moclobemide—Decreased appetite—Dactinomycin—testicular cancer	0.00123	0.00293	CcSEcCtD
Moclobemide—Diarrhoea—Vinblastine—testicular cancer	0.00123	0.00293	CcSEcCtD
Moclobemide—Dysgeusia—Etoposide—testicular cancer	0.00123	0.00293	CcSEcCtD
Moclobemide—Fatigue—Dactinomycin—testicular cancer	0.00122	0.00291	CcSEcCtD
Moclobemide—Hypotension—Ifosfamide—testicular cancer	0.00121	0.00289	CcSEcCtD
Moclobemide—Urticaria—Bleomycin—testicular cancer	0.0012	0.00287	CcSEcCtD
Moclobemide—Irritability—Methotrexate—testicular cancer	0.00119	0.00284	CcSEcCtD
Moclobemide—Dizziness—Vinblastine—testicular cancer	0.00119	0.00283	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.00118	0.00282	CcSEcCtD
Moclobemide—Osteoarthritis—Epirubicin—testicular cancer	0.00117	0.00278	CcSEcCtD
Moclobemide—Myalgia—Cisplatin—testicular cancer	0.00116	0.00278	CcSEcCtD
Moclobemide—Feeling abnormal—Dactinomycin—testicular cancer	0.00116	0.00278	CcSEcCtD
Moclobemide—Nausea—Chlorambucil—testicular cancer	0.00116	0.00277	CcSEcCtD
Moclobemide—Paraesthesia—Ifosfamide—testicular cancer	0.00116	0.00277	CcSEcCtD
Moclobemide—Ill-defined disorder—Etoposide—testicular cancer	0.00116	0.00277	CcSEcCtD
Moclobemide—Anxiety—Cisplatin—testicular cancer	0.00116	0.00277	CcSEcCtD
Moclobemide—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00115	0.00276	CcSEcCtD
Moclobemide—Dyspnoea—Ifosfamide—testicular cancer	0.00115	0.00275	CcSEcCtD
Moclobemide—Hot flush—Doxorubicin—testicular cancer	0.00115	0.00275	CcSEcCtD
Moclobemide—Somnolence—Ifosfamide—testicular cancer	0.00115	0.00275	CcSEcCtD
Moclobemide—Discomfort—Cisplatin—testicular cancer	0.00115	0.00275	CcSEcCtD
Moclobemide—Migraine—Epirubicin—testicular cancer	0.00115	0.00274	CcSEcCtD
Moclobemide—Menopausal symptoms—Doxorubicin—testicular cancer	0.00114	0.00273	CcSEcCtD
Moclobemide—Vomiting—Vinblastine—testicular cancer	0.00114	0.00272	CcSEcCtD
Moclobemide—Malaise—Etoposide—testicular cancer	0.00113	0.0027	CcSEcCtD
Moclobemide—Decreased appetite—Ifosfamide—testicular cancer	0.00112	0.00269	CcSEcCtD
Moclobemide—Headache—Vinblastine—testicular cancer	0.00112	0.00268	CcSEcCtD
Moclobemide—Abdominal pain—Dactinomycin—testicular cancer	0.00112	0.00267	CcSEcCtD
Moclobemide—Fatigue—Ifosfamide—testicular cancer	0.00112	0.00266	CcSEcCtD
Moclobemide—Constipation—Ifosfamide—testicular cancer	0.00111	0.00264	CcSEcCtD
Moclobemide—Loss of consciousness—Etoposide—testicular cancer	0.0011	0.00263	CcSEcCtD
Moclobemide—Tachycardia—Cisplatin—testicular cancer	0.00109	0.0026	CcSEcCtD
Moclobemide—Asthenia—Bleomycin—testicular cancer	0.00109	0.00259	CcSEcCtD
Moclobemide—Hypertension—Etoposide—testicular cancer	0.00108	0.00258	CcSEcCtD
Moclobemide—Osteoarthritis—Doxorubicin—testicular cancer	0.00108	0.00258	CcSEcCtD
Moclobemide—Hyperhidrosis—Cisplatin—testicular cancer	0.00108	0.00258	CcSEcCtD
Moclobemide—Pruritus—Bleomycin—testicular cancer	0.00107	0.00256	CcSEcCtD
Moclobemide—Dry skin—Epirubicin—testicular cancer	0.00107	0.00255	CcSEcCtD
Moclobemide—Feeling abnormal—Ifosfamide—testicular cancer	0.00107	0.00255	CcSEcCtD
Moclobemide—Chest pain—Etoposide—testicular cancer	0.00107	0.00255	CcSEcCtD
Moclobemide—Nausea—Vinblastine—testicular cancer	0.00106	0.00254	CcSEcCtD
Moclobemide—Migraine—Doxorubicin—testicular cancer	0.00106	0.00253	CcSEcCtD
Moclobemide—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00106	0.00253	CcSEcCtD
Moclobemide—Discomfort—Etoposide—testicular cancer	0.00105	0.00252	CcSEcCtD
Moclobemide—Hypotension—Cisplatin—testicular cancer	0.00104	0.00249	CcSEcCtD
Moclobemide—Gastritis—Epirubicin—testicular cancer	0.00103	0.00246	CcSEcCtD
Moclobemide—Confusional state—Etoposide—testicular cancer	0.00103	0.00246	CcSEcCtD
Moclobemide—Urticaria—Ifosfamide—testicular cancer	0.00103	0.00245	CcSEcCtD
Moclobemide—Abdominal pain—Ifosfamide—testicular cancer	0.00102	0.00244	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00102	0.00243	CcSEcCtD
Moclobemide—Abdominal distension—Epirubicin—testicular cancer	0.00101	0.00242	CcSEcCtD
Moclobemide—Asthenia—Dactinomycin—testicular cancer	0.00101	0.00242	CcSEcCtD
Moclobemide—Dysuria—Methotrexate—testicular cancer	0.00101	0.0024	CcSEcCtD
Moclobemide—Paraesthesia—Cisplatin—testicular cancer	0.001	0.00239	CcSEcCtD
Moclobemide—Tachycardia—Etoposide—testicular cancer	0.000997	0.00238	CcSEcCtD
Moclobemide—Dyspnoea—Cisplatin—testicular cancer	0.000994	0.00237	CcSEcCtD
Moclobemide—Dry skin—Doxorubicin—testicular cancer	0.000988	0.00236	CcSEcCtD
Moclobemide—Hyperhidrosis—Etoposide—testicular cancer	0.000988	0.00236	CcSEcCtD
Moclobemide—Angina pectoris—Epirubicin—testicular cancer	0.000981	0.00234	CcSEcCtD
Moclobemide—Decreased appetite—Cisplatin—testicular cancer	0.000969	0.00232	CcSEcCtD
Moclobemide—Diarrhoea—Dactinomycin—testicular cancer	0.000966	0.00231	CcSEcCtD
Moclobemide—Vomiting—Bleomycin—testicular cancer	0.000962	0.0023	CcSEcCtD
Moclobemide—Drowsiness—Methotrexate—testicular cancer	0.00096	0.00229	CcSEcCtD
Moclobemide—Hypotension—Etoposide—testicular cancer	0.000955	0.00228	CcSEcCtD
Moclobemide—Rash—Bleomycin—testicular cancer	0.000954	0.00228	CcSEcCtD
Moclobemide—Gastritis—Doxorubicin—testicular cancer	0.000954	0.00228	CcSEcCtD
Moclobemide—Dermatitis—Bleomycin—testicular cancer	0.000953	0.00228	CcSEcCtD
Moclobemide—Dysuria—Epirubicin—testicular cancer	0.000942	0.00225	CcSEcCtD
Moclobemide—Abdominal distension—Doxorubicin—testicular cancer	0.000938	0.00224	CcSEcCtD
Moclobemide—Stomatitis—Methotrexate—testicular cancer	0.000935	0.00223	CcSEcCtD
Moclobemide—Conjunctivitis—Methotrexate—testicular cancer	0.000933	0.00223	CcSEcCtD
Moclobemide—Asthenia—Ifosfamide—testicular cancer	0.000928	0.00222	CcSEcCtD
Moclobemide—Sweating—Methotrexate—testicular cancer	0.00092	0.0022	CcSEcCtD
Moclobemide—Feeling abnormal—Cisplatin—testicular cancer	0.000919	0.0022	CcSEcCtD
Moclobemide—Paraesthesia—Etoposide—testicular cancer	0.000917	0.00219	CcSEcCtD
Moclobemide—Pruritus—Ifosfamide—testicular cancer	0.000915	0.00219	CcSEcCtD
Moclobemide—Dyspnoea—Etoposide—testicular cancer	0.000911	0.00218	CcSEcCtD
Moclobemide—Somnolence—Etoposide—testicular cancer	0.000908	0.00217	CcSEcCtD
Moclobemide—Angina pectoris—Doxorubicin—testicular cancer	0.000908	0.00217	CcSEcCtD
Moclobemide—Nausea—Bleomycin—testicular cancer	0.000899	0.00215	CcSEcCtD
Moclobemide—Drowsiness—Epirubicin—testicular cancer	0.000898	0.00214	CcSEcCtD
Moclobemide—Vomiting—Dactinomycin—testicular cancer	0.000898	0.00214	CcSEcCtD
Moclobemide—Rash—Dactinomycin—testicular cancer	0.00089	0.00213	CcSEcCtD
Moclobemide—Decreased appetite—Etoposide—testicular cancer	0.000888	0.00212	CcSEcCtD
Moclobemide—Diarrhoea—Ifosfamide—testicular cancer	0.000885	0.00211	CcSEcCtD
Moclobemide—Fatigue—Etoposide—testicular cancer	0.000881	0.0021	CcSEcCtD
Moclobemide—Stomatitis—Epirubicin—testicular cancer	0.000875	0.00209	CcSEcCtD
Moclobemide—Constipation—Etoposide—testicular cancer	0.000874	0.00209	CcSEcCtD
Moclobemide—Conjunctivitis—Epirubicin—testicular cancer	0.000873	0.00208	CcSEcCtD
Moclobemide—Dysuria—Doxorubicin—testicular cancer	0.000871	0.00208	CcSEcCtD
Moclobemide—Sweating—Epirubicin—testicular cancer	0.000861	0.00206	CcSEcCtD
Moclobemide—Dizziness—Ifosfamide—testicular cancer	0.000855	0.00204	CcSEcCtD
Moclobemide—Feeling abnormal—Etoposide—testicular cancer	0.000842	0.00201	CcSEcCtD
Moclobemide—Nausea—Dactinomycin—testicular cancer	0.000838	0.002	CcSEcCtD
Moclobemide—Gastrointestinal pain—Etoposide—testicular cancer	0.000835	0.002	CcSEcCtD
Moclobemide—Drowsiness—Doxorubicin—testicular cancer	0.000831	0.00198	CcSEcCtD
Moclobemide—Visual impairment—Methotrexate—testicular cancer	0.00083	0.00198	CcSEcCtD
Moclobemide—Vomiting—Ifosfamide—testicular cancer	0.000822	0.00196	CcSEcCtD
Moclobemide—Bradycardia—Epirubicin—testicular cancer	0.000821	0.00196	CcSEcCtD
Moclobemide—Rash—Ifosfamide—testicular cancer	0.000816	0.00195	CcSEcCtD
Moclobemide—Dermatitis—Ifosfamide—testicular cancer	0.000815	0.00195	CcSEcCtD
Moclobemide—Urticaria—Etoposide—testicular cancer	0.000812	0.00194	CcSEcCtD
Moclobemide—Stomatitis—Doxorubicin—testicular cancer	0.00081	0.00193	CcSEcCtD
Moclobemide—Abdominal pain—Etoposide—testicular cancer	0.000808	0.00193	CcSEcCtD
Moclobemide—Conjunctivitis—Doxorubicin—testicular cancer	0.000808	0.00193	CcSEcCtD
Moclobemide—Tinnitus—Methotrexate—testicular cancer	0.000803	0.00192	CcSEcCtD
Moclobemide—Asthenia—Cisplatin—testicular cancer	0.0008	0.00191	CcSEcCtD
Moclobemide—Sweating—Doxorubicin—testicular cancer	0.000797	0.0019	CcSEcCtD
Moclobemide—Visual impairment—Epirubicin—testicular cancer	0.000777	0.00186	CcSEcCtD
Moclobemide—Nausea—Ifosfamide—testicular cancer	0.000768	0.00184	CcSEcCtD
Moclobemide—Diarrhoea—Cisplatin—testicular cancer	0.000763	0.00182	CcSEcCtD
Moclobemide—Bradycardia—Doxorubicin—testicular cancer	0.000759	0.00181	CcSEcCtD
Moclobemide—Tinnitus—Epirubicin—testicular cancer	0.000752	0.0018	CcSEcCtD
Moclobemide—Flushing—Epirubicin—testicular cancer	0.000748	0.00179	CcSEcCtD
Moclobemide—Dysgeusia—Methotrexate—testicular cancer	0.000734	0.00175	CcSEcCtD
Moclobemide—Asthenia—Etoposide—testicular cancer	0.000733	0.00175	CcSEcCtD
Moclobemide—Pruritus—Etoposide—testicular cancer	0.000723	0.00173	CcSEcCtD
Moclobemide—Visual impairment—Doxorubicin—testicular cancer	0.000719	0.00172	CcSEcCtD
Moclobemide—Vomiting—Cisplatin—testicular cancer	0.000709	0.00169	CcSEcCtD
Moclobemide—Vision blurred—Methotrexate—testicular cancer	0.000707	0.00169	CcSEcCtD
Moclobemide—Rash—Cisplatin—testicular cancer	0.000703	0.00168	CcSEcCtD
Moclobemide—Dermatitis—Cisplatin—testicular cancer	0.000702	0.00168	CcSEcCtD
Moclobemide—Diarrhoea—Etoposide—testicular cancer	0.000699	0.00167	CcSEcCtD
Moclobemide—Ill-defined disorder—Methotrexate—testicular cancer	0.000696	0.00166	CcSEcCtD
Moclobemide—Tinnitus—Doxorubicin—testicular cancer	0.000695	0.00166	CcSEcCtD
Moclobemide—Flushing—Doxorubicin—testicular cancer	0.000692	0.00165	CcSEcCtD
Moclobemide—Flatulence—Epirubicin—testicular cancer	0.000691	0.00165	CcSEcCtD
Moclobemide—Tension—Epirubicin—testicular cancer	0.000689	0.00164	CcSEcCtD
Moclobemide—Dysgeusia—Epirubicin—testicular cancer	0.000687	0.00164	CcSEcCtD
Moclobemide—Nervousness—Epirubicin—testicular cancer	0.000682	0.00163	CcSEcCtD
Moclobemide—Malaise—Methotrexate—testicular cancer	0.000676	0.00162	CcSEcCtD
Moclobemide—Dizziness—Etoposide—testicular cancer	0.000676	0.00161	CcSEcCtD
Moclobemide—Nausea—Cisplatin—testicular cancer	0.000662	0.00158	CcSEcCtD
Moclobemide—Vision blurred—Epirubicin—testicular cancer	0.000661	0.00158	CcSEcCtD
Moclobemide—Ill-defined disorder—Epirubicin—testicular cancer	0.000651	0.00156	CcSEcCtD
Moclobemide—Vomiting—Etoposide—testicular cancer	0.00065	0.00155	CcSEcCtD
Moclobemide—Agitation—Epirubicin—testicular cancer	0.000645	0.00154	CcSEcCtD
Moclobemide—Rash—Etoposide—testicular cancer	0.000644	0.00154	CcSEcCtD
Moclobemide—Dermatitis—Etoposide—testicular cancer	0.000644	0.00154	CcSEcCtD
Moclobemide—Headache—Etoposide—testicular cancer	0.00064	0.00153	CcSEcCtD
Moclobemide—Flatulence—Doxorubicin—testicular cancer	0.00064	0.00153	CcSEcCtD
Moclobemide—Chest pain—Methotrexate—testicular cancer	0.000638	0.00152	CcSEcCtD
Moclobemide—Myalgia—Methotrexate—testicular cancer	0.000638	0.00152	CcSEcCtD
Moclobemide—Tension—Doxorubicin—testicular cancer	0.000637	0.00152	CcSEcCtD
Moclobemide—Dysgeusia—Doxorubicin—testicular cancer	0.000636	0.00152	CcSEcCtD
Moclobemide—Malaise—Epirubicin—testicular cancer	0.000633	0.00151	CcSEcCtD
Moclobemide—Discomfort—Methotrexate—testicular cancer	0.000631	0.00151	CcSEcCtD
Moclobemide—Nervousness—Doxorubicin—testicular cancer	0.000631	0.00151	CcSEcCtD
Moclobemide—Syncope—Epirubicin—testicular cancer	0.000629	0.0015	CcSEcCtD
Moclobemide—Palpitations—Epirubicin—testicular cancer	0.00062	0.00148	CcSEcCtD
Moclobemide—Confusional state—Methotrexate—testicular cancer	0.000617	0.00147	CcSEcCtD
Moclobemide—Loss of consciousness—Epirubicin—testicular cancer	0.000617	0.00147	CcSEcCtD
Moclobemide—Vision blurred—Doxorubicin—testicular cancer	0.000612	0.00146	CcSEcCtD
Moclobemide—Nausea—Etoposide—testicular cancer	0.000607	0.00145	CcSEcCtD
Moclobemide—Hypertension—Epirubicin—testicular cancer	0.000606	0.00145	CcSEcCtD
Moclobemide—Ill-defined disorder—Doxorubicin—testicular cancer	0.000602	0.00144	CcSEcCtD
Moclobemide—Chest pain—Epirubicin—testicular cancer	0.000597	0.00143	CcSEcCtD
Moclobemide—Myalgia—Epirubicin—testicular cancer	0.000597	0.00143	CcSEcCtD
Moclobemide—Agitation—Doxorubicin—testicular cancer	0.000597	0.00143	CcSEcCtD
Moclobemide—Anxiety—Epirubicin—testicular cancer	0.000595	0.00142	CcSEcCtD
Moclobemide—Hyperhidrosis—Methotrexate—testicular cancer	0.000592	0.00141	CcSEcCtD
Moclobemide—Discomfort—Epirubicin—testicular cancer	0.00059	0.00141	CcSEcCtD
Moclobemide—Malaise—Doxorubicin—testicular cancer	0.000586	0.0014	CcSEcCtD
Moclobemide—Dry mouth—Epirubicin—testicular cancer	0.000584	0.0014	CcSEcCtD
Moclobemide—Syncope—Doxorubicin—testicular cancer	0.000582	0.00139	CcSEcCtD
Moclobemide—Confusional state—Epirubicin—testicular cancer	0.000577	0.00138	CcSEcCtD
Moclobemide—Palpitations—Doxorubicin—testicular cancer	0.000574	0.00137	CcSEcCtD
Moclobemide—Hypotension—Methotrexate—testicular cancer	0.000572	0.00137	CcSEcCtD
Moclobemide—Loss of consciousness—Doxorubicin—testicular cancer	0.000571	0.00136	CcSEcCtD
Moclobemide—Shock—Epirubicin—testicular cancer	0.000563	0.00135	CcSEcCtD
Moclobemide—Hypertension—Doxorubicin—testicular cancer	0.000561	0.00134	CcSEcCtD
Moclobemide—Tachycardia—Epirubicin—testicular cancer	0.000559	0.00134	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000558	0.00133	CcSEcCtD
Moclobemide—Hyperhidrosis—Epirubicin—testicular cancer	0.000554	0.00132	CcSEcCtD
Moclobemide—Insomnia—Methotrexate—testicular cancer	0.000553	0.00132	CcSEcCtD
Moclobemide—Chest pain—Doxorubicin—testicular cancer	0.000553	0.00132	CcSEcCtD
Moclobemide—Myalgia—Doxorubicin—testicular cancer	0.000553	0.00132	CcSEcCtD
Moclobemide—Anxiety—Doxorubicin—testicular cancer	0.000551	0.00132	CcSEcCtD
Moclobemide—Paraesthesia—Methotrexate—testicular cancer	0.00055	0.00131	CcSEcCtD
Moclobemide—Discomfort—Doxorubicin—testicular cancer	0.000546	0.0013	CcSEcCtD
Moclobemide—Dyspnoea—Methotrexate—testicular cancer	0.000546	0.0013	CcSEcCtD
Moclobemide—Somnolence—Methotrexate—testicular cancer	0.000544	0.0013	CcSEcCtD
Moclobemide—Dry mouth—Doxorubicin—testicular cancer	0.000541	0.00129	CcSEcCtD
Moclobemide—Dyspepsia—Methotrexate—testicular cancer	0.000539	0.00129	CcSEcCtD
Moclobemide—Hypotension—Epirubicin—testicular cancer	0.000535	0.00128	CcSEcCtD
Moclobemide—Confusional state—Doxorubicin—testicular cancer	0.000534	0.00128	CcSEcCtD
Moclobemide—Decreased appetite—Methotrexate—testicular cancer	0.000532	0.00127	CcSEcCtD
Moclobemide—Fatigue—Methotrexate—testicular cancer	0.000528	0.00126	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000522	0.00125	CcSEcCtD
Moclobemide—Shock—Doxorubicin—testicular cancer	0.000521	0.00125	CcSEcCtD
Moclobemide—Insomnia—Epirubicin—testicular cancer	0.000518	0.00124	CcSEcCtD
Moclobemide—Tachycardia—Doxorubicin—testicular cancer	0.000517	0.00124	CcSEcCtD
Moclobemide—Paraesthesia—Epirubicin—testicular cancer	0.000514	0.00123	CcSEcCtD
Moclobemide—Hyperhidrosis—Doxorubicin—testicular cancer	0.000512	0.00122	CcSEcCtD
Moclobemide—Dyspnoea—Epirubicin—testicular cancer	0.000511	0.00122	CcSEcCtD
Moclobemide—Somnolence—Epirubicin—testicular cancer	0.000509	0.00122	CcSEcCtD
Moclobemide—Feeling abnormal—Methotrexate—testicular cancer	0.000504	0.0012	CcSEcCtD
Moclobemide—Dyspepsia—Epirubicin—testicular cancer	0.000504	0.0012	CcSEcCtD
Moclobemide—Gastrointestinal pain—Methotrexate—testicular cancer	0.0005	0.0012	CcSEcCtD
Moclobemide—Decreased appetite—Epirubicin—testicular cancer	0.000498	0.00119	CcSEcCtD
Moclobemide—Hypotension—Doxorubicin—testicular cancer	0.000495	0.00118	CcSEcCtD
Moclobemide—Fatigue—Epirubicin—testicular cancer	0.000494	0.00118	CcSEcCtD
Moclobemide—Constipation—Epirubicin—testicular cancer	0.00049	0.00117	CcSEcCtD
Moclobemide—Urticaria—Methotrexate—testicular cancer	0.000486	0.00116	CcSEcCtD
Moclobemide—Abdominal pain—Methotrexate—testicular cancer	0.000484	0.00116	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000483	0.00115	CcSEcCtD
Moclobemide—Insomnia—Doxorubicin—testicular cancer	0.000479	0.00114	CcSEcCtD
Moclobemide—Paraesthesia—Doxorubicin—testicular cancer	0.000476	0.00114	CcSEcCtD
Moclobemide—Dyspnoea—Doxorubicin—testicular cancer	0.000472	0.00113	CcSEcCtD
Moclobemide—Feeling abnormal—Epirubicin—testicular cancer	0.000472	0.00113	CcSEcCtD
Moclobemide—Somnolence—Doxorubicin—testicular cancer	0.000471	0.00113	CcSEcCtD
Moclobemide—Gastrointestinal pain—Epirubicin—testicular cancer	0.000468	0.00112	CcSEcCtD
Moclobemide—Dyspepsia—Doxorubicin—testicular cancer	0.000466	0.00111	CcSEcCtD
Moclobemide—Decreased appetite—Doxorubicin—testicular cancer	0.000461	0.0011	CcSEcCtD
Moclobemide—Fatigue—Doxorubicin—testicular cancer	0.000457	0.00109	CcSEcCtD
Moclobemide—Urticaria—Epirubicin—testicular cancer	0.000455	0.00109	CcSEcCtD
Moclobemide—Constipation—Doxorubicin—testicular cancer	0.000453	0.00108	CcSEcCtD
Moclobemide—Abdominal pain—Epirubicin—testicular cancer	0.000453	0.00108	CcSEcCtD
Moclobemide—Asthenia—Methotrexate—testicular cancer	0.000439	0.00105	CcSEcCtD
Moclobemide—Feeling abnormal—Doxorubicin—testicular cancer	0.000437	0.00104	CcSEcCtD
Moclobemide—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000433	0.00104	CcSEcCtD
Moclobemide—Pruritus—Methotrexate—testicular cancer	0.000433	0.00103	CcSEcCtD
Moclobemide—Urticaria—Doxorubicin—testicular cancer	0.000421	0.00101	CcSEcCtD
Moclobemide—Abdominal pain—Doxorubicin—testicular cancer	0.000419	0.001	CcSEcCtD
Moclobemide—Diarrhoea—Methotrexate—testicular cancer	0.000419	0.001	CcSEcCtD
Moclobemide—Asthenia—Epirubicin—testicular cancer	0.000411	0.000981	CcSEcCtD
Moclobemide—Pruritus—Epirubicin—testicular cancer	0.000405	0.000968	CcSEcCtD
Moclobemide—Dizziness—Methotrexate—testicular cancer	0.000405	0.000967	CcSEcCtD
Moclobemide—Diarrhoea—Epirubicin—testicular cancer	0.000392	0.000936	CcSEcCtD
Moclobemide—Vomiting—Methotrexate—testicular cancer	0.000389	0.000929	CcSEcCtD
Moclobemide—Rash—Methotrexate—testicular cancer	0.000386	0.000922	CcSEcCtD
Moclobemide—Dermatitis—Methotrexate—testicular cancer	0.000385	0.000921	CcSEcCtD
Moclobemide—Headache—Methotrexate—testicular cancer	0.000383	0.000916	CcSEcCtD
Moclobemide—Asthenia—Doxorubicin—testicular cancer	0.00038	0.000908	CcSEcCtD
Moclobemide—Dizziness—Epirubicin—testicular cancer	0.000379	0.000905	CcSEcCtD
Moclobemide—Pruritus—Doxorubicin—testicular cancer	0.000375	0.000895	CcSEcCtD
Moclobemide—Vomiting—Epirubicin—testicular cancer	0.000364	0.00087	CcSEcCtD
Moclobemide—Nausea—Methotrexate—testicular cancer	0.000363	0.000868	CcSEcCtD
Moclobemide—Diarrhoea—Doxorubicin—testicular cancer	0.000363	0.000866	CcSEcCtD
Moclobemide—Rash—Epirubicin—testicular cancer	0.000361	0.000863	CcSEcCtD
Moclobemide—Dermatitis—Epirubicin—testicular cancer	0.000361	0.000862	CcSEcCtD
Moclobemide—Headache—Epirubicin—testicular cancer	0.000359	0.000857	CcSEcCtD
Moclobemide—Dizziness—Doxorubicin—testicular cancer	0.00035	0.000837	CcSEcCtD
Moclobemide—Nausea—Epirubicin—testicular cancer	0.00034	0.000813	CcSEcCtD
Moclobemide—Vomiting—Doxorubicin—testicular cancer	0.000337	0.000805	CcSEcCtD
Moclobemide—Rash—Doxorubicin—testicular cancer	0.000334	0.000798	CcSEcCtD
Moclobemide—Dermatitis—Doxorubicin—testicular cancer	0.000334	0.000797	CcSEcCtD
Moclobemide—Headache—Doxorubicin—testicular cancer	0.000332	0.000793	CcSEcCtD
Moclobemide—Nausea—Doxorubicin—testicular cancer	0.000315	0.000752	CcSEcCtD
